World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
47561
World Ranking
5959
National Ranking
3187

James H. Doroshow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James H. Doroshow sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 853 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James H. Doroshow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James H. Doroshow sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James H. Doroshow is affiliated with the National Institutes of Health in the United States and has a substantial portfolio of research within biochemistry, genetics, molecular biology, and medicine. Their work spans multiple subfields, particularly molecular biology, oncology, cancer research, pulmonary and respiratory medicine, and immunology.

The scientist's research topics focus largely on cancer genomics and diagnostics, epigenetics and DNA methylation, cancer cells and metastasis, sarcoma diagnosis and treatment, computational drug discovery methods, radiomics and machine learning in medical imaging, and cancer research and treatments.

James H. Doroshow has authored numerous papers, contributing to the following recent publications:

  • TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository, 2021, Journal of Translational Medicine
  • Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts, 2021, Nature Genetics
  • The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment, 2021, Cell
  • Converting tabular data into images for deep learning with convolutional neural networks, 2021, Scientific Reports
  • The NCI-MATCH trial: lessons for precision oncology, 2023, Nature Medicine

Doroshow collaborates frequently with a core group of researchers, including:

  • Yvonne A. Evrard
  • Alice P. Chen
  • Melinda G. Hollingshead
  • Ralph E. Parchment
  • Chris Karlovich

Their publications are frequently found in specialized journals such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Molecular Cancer Therapeutics
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

James H. Doroshow has also contributed to scholarly books, including a notable publication with Elsevier BV: "Abeloff's Clinical Oncology," published in 2020.

Best Publications

  • Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

    Junko Murai;Shar Yin N. Huang;Benu Brata Das;Amelie Renaud

  • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate by the advanced colorectal cancer meta-analysis project

    P. Piedbois;M. Buyse;Y. Rustum;D. Machover

  • Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites: ALTERATIONS PRODUCED BY DOXORUBICIN

    James H. Doroshow;Gershon Y. Locker;C. E. Myers

  • CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set

    William C. Reinhold;Margot Sunshine;Margot Sunshine;Hongfang Liu;Sudhir Varma

  • Effect of Anthracycline Antibiotics on Oxygen Radical Formation in Rat Heart

    James H. Doroshow

  • Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

    Junko Murai;Shar-yin N. Huang;Amèlie Renaud;Yiping Zhang

  • Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-Gi

    Fong-Fong Chu;J. H. Doroshow;R. S. Esworthy

  • Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

    Alan F. List;Kenneth J. Kopecky;Cheryl L. Willman;David R. Head

  • Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors

    Janneke E. Jaspers;Ariena Kersbergen;Ute Boon;Wendy Sol

  • Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

    C G Leichman;T R Fleming;F M Muggia;C M Tangen

  • Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.

    K A Margolin;A A Rayner;M J Hawkins;M B Atkins

  • Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

    Shivaani Kummar;Robert Kinders;Martin E. Gutierrez;Larry Rubinstein

  • Anthracycline Antibiotic-stimulated Superoxide, Hydrogen Peroxide, and Hydroxyl Radical Production by NADH Dehydrogenase

    James H. Doroshow

  • Mice with combined disruption of Gpx1 and Gpx2 genes have colitis.

    R. Steven Esworthy;Richard Aranda;Martín G. Martín;James H. Doroshow

  • Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes.

    Fong Fong Chu;R. Steven Esworthy;Peiguo G. Chu;Jeffrey A. Longmate

  • Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

    Susan L. Holbeck;Jerry M. Collins;James H. Doroshow

  • Abeloff's Clinical Oncology

    John E. Niederhuber;James O. Armitage;James H. Doroshow;Michael B. Kastan

  • Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.

    K G Blume;S J Forman;M R O'Donnell;J H Doroshow

  • Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.

    J H Doroshow;G Y Locker;I Ifrim;C E Myers

  • Histone γH2AX and Poly(ADP-Ribose) as Clinical Pharmacodynamic Biomarkers

    Christophe E Redon;Asako J Nakamura;Yong-Wei Zhang;Jiuping Jay Ji

Frequent Co-Authors

Kim Margolin
Kim Margolin City Of Hope National Medical Center
George Somlo
George Somlo City Of Hope National Medical Center
Yves Pommier
Yves Pommier National Institutes of Health
David R. Gandara
David R. Gandara University of California, Davis
Jerry M. Collins
Jerry M. Collins National Institutes of Health
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
William C. Reinhold
William C. Reinhold National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Primo N. Lara
Primo N. Lara University of California, Davis
Stephen J. Forman
Stephen J. Forman City Of Hope National Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Medicine in the USA, it’s important to consider flexible degree options and alternative career pathways in healthcare. Online programs are becoming increasingly popular, offering convenience and accessibility for busy students and working professionals.

For those interested in advancing into healthcare administration, consider cahme-accredited online mha programs. These programs are recognized for their quality, preparing graduates for leadership roles in hospitals and healthcare organizations.

Nurses looking to enhance their qualifications may benefit from online rn to bsn programs no clinicals, which provide a streamlined path to your bachelor’s degree without the need for additional clinical hours.

Those pursuing advanced practice can explore the shortest dnp programs online for a quicker route to a Doctor of Nursing Practice. For cost-conscious students, affordable dnp programs can help make doctoral education more accessible.

These online degrees can open doors to a variety of rewarding roles in healthcare, supporting both clinical and administrative career ambitions.

Best Scientists Citing James H. Doroshow

Trending Scientists

Recently Published Articles